Efficacy and Safety Study of Oral Eligen® B12 in Subjects With Low Serum Cobalamin
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Benno Roesch, MD
Frontage (formerly ABR), 241 Main Street, Hackensack, NJ 07601 USA
Principal Investigator - Michael M. Rothkopf, MD
South Mountain Medical Consultants, 1500 Pleasant Valley Way, Suite 201, West Orange, NJ 07052 USA
Principal Investigator - Mitchell K. Spinnell, MD
Gastroenterology, 1555 Center Avenue, Fort Lee, NJ 07024 USA
Principal Investigator - Nancy Allegar, MD
Alatae Medical LLC, 390 Amwell Road, Building 5, Hillsborough, NJ 08844 USA
Principal Investigator - Peter Varunok, MD
Gastroenterology Associates, 243 North Road, Suite 304, Poughkeepsie, NY 12601 USA
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
No facility list is in our current data snapshot for this study. The registry record on ClinicalTrials.gov ↗ carries any published locations. Why? →
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 28 Feb 2009
- Primary completion
- —
- Completion
- 31 Dec 2010
- Last update posted
- 11 Mar 2011
- Registered enrollment
- 49
- Registry id
- NCT01312831
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.